Epigallocatechin 3-gallate (EGCG), an abundant polyphenolic component derived from
green tea extract, possesses versatile bioactivities that can combat many diseases. During …

Oxidative stress and neuroinflammation are common bases for disease onset and
progression in many neurodegenerative diseases. In Parkinson disease, which is …

Recent technological improvements have positioned us at the threshold of innovative
discoveries that will assist in new perspectives and avenues of research. Increased attention …

A pathological feature of Parkinson's disease (PD) is the progressive loss of dopaminergic
neurons and decreased dopamine (DA) content in the substantia nigra pars compacta in PD …

Drug-induced movement disorders affect a significant percentage of individuals, and they
are commonly overlooked and underdiagnosed in clinical practice. Many comorbidities can …

Many conditions can benefit from RNA-based therapies, namely, those targeting internal
ribosome entry sites (IRESs) and their regulatory proteins, the IRES trans-acting factors …

A time span of 60 years covers the detection of catecholamines in the brain, their function in
movement and correlation to Parkinson's disease (PD). The clinical findings that orally given …

Extracellular vesicles (EVs) are membrane‐enclosed nanovesicles secreted by cells into the
extracellular space and contain functional biomolecules, eg signaling receptors, bioactive …

In recent years, there has been an increased demand for highly sensitive and selective
biosensors for neurotransmitters, owing to advancements in science and technology. Real …

Neuroimaging can provide significant benefits in evaluating patients with movement
disorders associated with drugs. This literature review describes neuroimaging techniques …